TY  - CHAP
M1  - Book, Section
TI  - Prostate cancer screening
A1  - Marietti, Sarah
A1  - Albertsen, Peter C.
A2  - Feneley, Mark R.
A2  - Payne, Heather A.
PY  - 2018
T2  - Therapeutic Strategies in Prostate Cancer
AB  - When  planning  a  screening  programme  for  any  disease,  five  key  questions  should  be  addressed  [1].  Is  the  test  screening  for  a  significant,  serious  disease?  Are  the  tests  used  to  screen  for  the  condition  accurate?  Is  the  outcome  of  the  disease  changed  or  improved  by  the  use  of  the  screening  test?  Does  screening  cause  the  patient  harm?  Does  the  screening  produce  more  good  than  harm?  This  chapter  will  review  each  of  these  questions  in  an  attempt  to  address  the  appropriateness  of  prostate  cancer  screening  in  contemporary  medical  practice.  
SN  - 
PB  - Clinical Publishing
CY  - New York, NY
Y2  - 2021/01/27
UR  - hemonc.mhmedical.com/content.aspx?aid=1152370807
ER  -